HUMAN ANTI-ENDOPLASMIC RETICULUM AUTOANTIBODIES PRODUCED IN AROMATIC ANTICONVULSANT HYPERSENSITIVITY REACTIONS RECOGNIZE RODENT CYP3A PROTEINS AND A SIMILARLY REGULATED HUMAN P450 ENZYME(S)

被引:38
作者
RILEY, RJ
SMITH, G
WOLF, CR
COOK, VA
LEEDER, JS
机构
[1] IMPERIAL CANC RES FUND,MOLEC PHARMACOL LAB,EDINBURGH,SCOTLAND
[2] HOSP SICK CHILDREN,DEPT PAEDIAT,DIV CLIN PHARMACOL & TOXICOL,TORONTO M5G 1X8,ONTARIO,CANADA
关键词
D O I
10.1006/bbrc.1993.1180
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypersensitivity reactions to aromatic anticonvulsants are associated with anti-liver microsomal antibodies which recognise rodent proteins. The reactivity of these antibodies, the regulation of the rodent antigens and the identity of the human autoantigen have been investigated. Dexamethasone elevated markedly the levels of an immunoreactive mouse protein(s) which exhibited a Mr (53 kDa) and inducibility consistent with the major Cyp3a product. Immunoblots conducted with hepatic microsomes from control and induced rats and purified rat P450s confirmed that these antibodies also recognised constitutive (3A2) and inducible (3A1) rat CYP3A products. Negligible reactivity was observed with microsomes from human B-lymphoblastoid cell lines expressing CYP1A1, 1A2, 2A6, 2D6, 2E1, 3A4 or epoxide hydrolase. Analysis of a phenotyped human liver bank revealed that the antibodies recognised a 52.5 kDa microsomal protein which exhibited marked heterogeneity in its expression and appeared to be regulated co-ordinately with human CYP2C8 and 3A3/4. The inter-individual variation in the expression of this protein(s) and its potential induction by anticonvulsant therapy together with an inherited deficiency in drug detoxification capacity may explain predisposition to these immunoallergic reactions. © 1993 Academic Press.
引用
收藏
页码:32 / 40
页数:9
相关论文
共 36 条
  • [21] POHL LR, 1988, ANNU REV PHARMACOL, V28, P367
  • [22] PONS C, 1991, J PHARMACOL EXP THER, V259, P1328
  • [23] CARBAMAZEPINE-INDUCED THROMBOCYTOPENIA, RASH, AND HEPATIC-DYSFUNCTION
    PONTE, CD
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (09): : 642 - 644
  • [24] AN INVITRO STUDY OF THE MICROSOMAL METABOLISM AND CELLULAR TOXICITY OF PHENYTOIN, SORBINIL AND MIANSERIN
    RILEY, RJ
    MAGGS, JL
    LAMBERT, C
    KITTERINGHAM, NR
    PARK, BK
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (05) : 577 - 588
  • [25] FORMATION OF CYTOTOXIC METABOLITES FROM PHENYTOIN, IMIPRAMINE, DESIPRAMINE, AMITRIPTYLINE AND MIANSERIN BY MOUSE AND HUMAN HEPATIC MICROSOMES
    RILEY, RJ
    ROBERTS, P
    KITTERINGHAM, NR
    PARK, BK
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 39 (12) : 1951 - 1958
  • [26] CLONING AND EXPRESSION OF COMPLEMENTARY DNAS FOR MULTIPLE MEMBERS OF THE HUMAN CYTOCHROME-P450IIC SUBFAMILY
    ROMKES, M
    FALETTO, MB
    BLAISDELL, JA
    RAUCY, JL
    GOLDSTEIN, JA
    [J]. BIOCHEMISTRY, 1991, 30 (13) : 3247 - 3255
  • [27] ROY D, 1990, J PHARMACOL EXP THER, V252, P895
  • [28] ANTICONVULSANT HYPERSENSITIVITY SYNDROME - INVITRO ASSESSMENT OF RISK
    SHEAR, NH
    SPIELBERG, SP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (06) : 1826 - 1832
  • [29] SKODA RC, 1988, J BIOL CHEM, V263, P1549
  • [30] SOUCEK P, 1992, XENOBIOTICA, V22, P83